×
About 79 results

ALLMedicine™ Pediatric Hepatocellular Carcinoma Center

Research & Reviews  39 results

Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatri...
https://doi.org/10.1097/MPH.0000000000002089
Journal of Pediatric Hematology/oncology; Whitlock RS, Loo C et. al.

Mar 26th, 2021 - Children with unresectable hepatocellular carcinoma (HCC) have a poor prognosis and limited treatment options. Transarterial radioembolization (TARE) using Yttrium-90 (Y90) has emerged as a potential bridge therapy to hepatic resection or transpla...

Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellul...
https://doi.org/10.1148/radiol.2021203559
Radiology Khanna G, Chavhan GB et. al.

Feb 23rd, 2021 - Background The Liver Imaging Reporting and Data System (LI-RADS) has standardized the evaluation of adult but not pediatric hepatocellular carcinoma (HCC). Purpose To evaluate the performance of LI-RADS version 2018 for diagnosis of pediatric HCC....

Surgical management of pediatric hepatocellular carcinoma: An analysis of the National ...
https://doi.org/10.1016/j.jpedsurg.2020.06.013
Journal of Pediatric Surgery; Ziogas IA, Benedetti DJ et. al.

Jun 17th, 2020 - This study evaluates overall survival (OS) between liver transplantation (LT) and liver resection (LR), while assessing the effect of margin status, in children with hepatocellular carcinoma (HCC). The National Cancer Database was queried (2004-20...

Clinical heterogeneity of pediatric hepatocellular carcinoma.
https://doi.org/10.1002/pbc.28307
Pediatric Blood & Cancer RERERENCES; D'Souza AM, Towbin AJ et. al.

Apr 20th, 2020 - Hepatocellular carcinoma (HCC) is often a chemoresistant neoplasm with a poor prognosis. Pediatric HCC may reflect unique biological and clinical heterogeneity. An IRB-approved retrospective institutional review of patients with HCC treated betwee...

see more →

Guidelines  1 results

2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood r...
https://doi.org/10.1007/s00247-018-4078-z
Pediatric Radiology; Towbin AJ, Meyers RL et. al.

Feb 10th, 2018 - Imaging is crucial in the assessment of children with a primary hepatic malignancy. Since its inception in 1992, the PRETEXT (PRE-Treatment EXTent of tumor) system has become the primary method of risk stratification for hepatoblastoma and pediatr...

see more →

Clinicaltrials.gov  39 results

Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatri...
https://doi.org/10.1097/MPH.0000000000002089
Journal of Pediatric Hematology/oncology; Whitlock RS, Loo C et. al.

Mar 26th, 2021 - Children with unresectable hepatocellular carcinoma (HCC) have a poor prognosis and limited treatment options. Transarterial radioembolization (TARE) using Yttrium-90 (Y90) has emerged as a potential bridge therapy to hepatic resection or transpla...

Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellul...
https://doi.org/10.1148/radiol.2021203559
Radiology Khanna G, Chavhan GB et. al.

Feb 23rd, 2021 - Background The Liver Imaging Reporting and Data System (LI-RADS) has standardized the evaluation of adult but not pediatric hepatocellular carcinoma (HCC). Purpose To evaluate the performance of LI-RADS version 2018 for diagnosis of pediatric HCC....

Surgical management of pediatric hepatocellular carcinoma: An analysis of the National ...
https://doi.org/10.1016/j.jpedsurg.2020.06.013
Journal of Pediatric Surgery; Ziogas IA, Benedetti DJ et. al.

Jun 17th, 2020 - This study evaluates overall survival (OS) between liver transplantation (LT) and liver resection (LR), while assessing the effect of margin status, in children with hepatocellular carcinoma (HCC). The National Cancer Database was queried (2004-20...

Clinical heterogeneity of pediatric hepatocellular carcinoma.
https://doi.org/10.1002/pbc.28307
Pediatric Blood & Cancer RERERENCES; D'Souza AM, Towbin AJ et. al.

Apr 20th, 2020 - Hepatocellular carcinoma (HCC) is often a chemoresistant neoplasm with a poor prognosis. Pediatric HCC may reflect unique biological and clinical heterogeneity. An IRB-approved retrospective institutional review of patients with HCC treated betwee...

see more →